Search

Search Results

• Oncological pathology in type 2 diabetes patients and its effects on the effectiveness of the treatment of diabetes

  Z. G. Krushinska, T. Yu. Yuzvenko

  337-348

  2019-11-29
• Advancement level of mobile applications intended for type 1 diabetes therapy supporting

  Tomasz Jerzy Nowicki, Grzegorz Józef Nowicki, Barbara Ślusarska

  704-713

  2020-09-26
• Pathophysiological association of expression hormone of adipose tissue omentin-1 and the degree of vascular remodeling of brachyocephalic vessels in persons with obesity and disorders of carbohydrate metabolism

  Roman Leonidovich Kulynych, Olena Anatolyevna Soloviuk, Oleksandr Olegovich Soloviuk

  127-143

  2020-10-30
• The impact of demographics on the prevalence and treatment of type 2 diabetes - a literature review

  Patryk Gadziński, Marta Czechowicz, Joanna Madoń

  67335

  2025-12-19
• Obesity, type 2 diabetes and hormone replacement therapy vs. colorectal tumors in the elderly

  Małgorzata Szamocka, Monika Anna Ameryk, Agnieszka Meder, Alina Sokup, Maciej Świątkowski

  230-243

  2017-06-15
• Ultrasound therapy of diabetes mellitus type 2

  I. Samosiuk, S. Zubkova, E. Chuhraeva, N. Samosiuk, W. Zukow

  68-74

  2011-02-20
• Icodec insulin - revolution in diabetes type 2 insulin therapy

  Michał Dobrzyński, Jakub Czarnota, Tomasz Skubel, Małgorzata Drozd, Iga Dudek, Natalia Rybak

  1136-1142

  2022-08-25
• Stronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment

  Hanna Sitarek, Adrianna Tabeau, Joanna Prus, Justyna Pięta, Agnieszka Pawlik, Patryk Dudek, Klaudia Łuczak, Wiktoria Ulicka, Marcel Chudzikowski, Agata Prokopiuk

  59642

  2025-05-06
• The role of the gut microbiota in the pathogenesis and therapy of type 2 diabetes mellitus

  Aleksandra Madej, Hanna Senat, Patrycja Grabowska, Patrycja Bolla, Aleksandra Senat, Zuzanna Marczyńska, Anna Niemczyk, Mateusz Dorochowicz

  38-51

  2024-01-22
• Experience of Magnesium and L-Carnitine Combine Use for Correction of Structural and Functional Heart Changes in Type 2 Diabetic Patients with End-Stage Kidney Disease

  Oleksandr Susla, Zoriana Litovkina, Inna Yakubyshyna

  286-303

  2020-12-28
• Pioglitazone - the forgotten drug with multidirectional action

  Arkadiusz Aab, Julia Zarańska

  11-19

  2023-04-25
• Optimization of treatment of patients with ischemic heart disease after suffering intervention in the coronary arteries

  Y. I. Karpenko, O. V. Blikhar

  560-566

  2016-08-26
• Diabetic peripheral neuropathy - advances in diagnosis and treatment

  Paula Bigos, Konrad Dendys, Jan Bieniasz, Wojciech Kuźnicki, Igor Matkowski, Piotr Potyrała

  89-106

  2023-07-25
• The Impact of GLP-1 Receptor Agonists on Women's Reproductive Health: A Review

  Marta Wolszczak, Hanna Wołodkiewicz, Jakub Szmit

  60194

  2025-06-05
• Metformin in Breast Cancer: Molecular Mechanisms, Preclinical Evidence and Clinical Implications

  Ewelina Nowicka, Izabela Brynczka , Klaudia Martyna Patrzykąt, Zofia Gorzoch-Burduk, Julia Puzio, Paula Marcinkowska, Marta Krzyżaniak, Michał Jezierski , Kinga Popielarska, Kamila Wróblewska

  66918

  2025-12-13